The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer

被引：0
|
作者：
Sada, Yvonne [1 ]
Duan, Zhigang [1 ]
El-Serag, Hashem [1 ]
Davila, Jessica [1 ]
机构：
[1] Michael E DeBakey VA Med Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 34期
关键词：
D O I：
10.1200/jco.2012.30.34_suppl.180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
180
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [2] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    [J]. JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [3] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    [J]. DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [4] Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer
    Cakar, B.
    Varol, U.
    Junushova, B.
    Muslu, U.
    Oner, P. Gursoy
    Surmeli, Z. Gokhan
    Cirak, Y.
    Karaca, B.
    Sezgin, C.
    Karabulut, B.
    Uslu, R.
    [J]. JOURNAL OF BUON, 2013, 18 (02): : 372 - 376
  • [5] Cost-effectiveness of adjuvant chemotherapy for patients with high-risk stage II and stage III colon cancer in South Africa.
    Pumpalova, Yoanna S.
    Rogers, Alexandra M.
    Tan, Sarah Xinhui
    Herbst, Candice-Lee
    Ruff, Paul
    Neugut, Alfred I.
    Hur, Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
    Hu, Huabin
    Wu, Zehua
    Wang, Chao
    Huang, Yan
    Zhang, Jianwei
    Cai, Yue
    Xie, Xiaoyu
    Li, Jianxia
    Shen, Cailu
    Li, Weiwei
    Ling, Jiayu
    Xu, Xuehu
    Deng, Yanhong
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa
    Tan, Sarah Xinhui
    Pumpalova, Yoanna
    Rogers, Alexandra M. M.
    Bhatt, Kishan
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I. I.
    Hur, Chin
    [J]. CANCER MEDICINE, 2023, 12 (14): : 15515 - 15529
  • [8] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON OVERALL SURVIVAL OF STAGE II AND III COLON CANCER
    Sekkate, Sakina
    Abahssain, Halima
    Serji, Badr
    Boutayeb, Saber
    Mrabti, Hind
    Errihani, Hassan
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v88 - v88
  • [9] IDENTIFICATION OF HIGH-RISK PATIENTS IN STAGE II COLON CANCER
    Lanza, Giovanni
    Gafa, Roberta
    Santini, Alessandra
    Maestri, Iva
    Guerzoni, Laura
    Liboni, Alberto
    Azzena, Gianfranco
    Lelli, Giorgio
    Cavazzini, Luigi
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 66 - 66
  • [10] Biomarker for high-risk patients with stage II colon cancer
    Watanabe, Toshiaki
    [J]. LANCET ONCOLOGY, 2013, 14 (13): : 1247 - 1248
12345